8512 Nucleic Acids Research, 2016, Vol. 44, No. 17 doi: 10.1093/nar/gkw618

Published online 5 July 2016

Corrigendum Editorial: CRISPR in Nucleic Acids Research Barry L. Stoddard1,† and Keith Fox2,† 1

Division of Basic Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N. A3-025, Seattle, WA 98109, USA and 2 Centre for Biological Sciences, Life Sciences Building 85, University of Southampton, Southampton SO17 1BJ, UK

Nucl. Acids Res. (20 June 2016) 44 (11): 4989–4990. doi: 10.1093/nar/gkw451 The Editors inadvertently omitted reference 18, which should have been cited on page 4989 in the following sentence: “Since the first descriptions of how the CRISPR/Cas9 molecular complex can be organized and used for targeted gene modification (6–8,18), the number of studies citing ‘CRISPR + Cas9’, as indexed in PubMed, has exploded from four papers in 2012 to a projection of over 2000 publications in 2016.” REFERENCE 18. Gasiunas,G., Barrangou,R., Horvath,P. and Siksnys,V. (2012) Cas9–crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. PNAS, 109, E2579–E2586.



Senior Editors, Nucleic Acids Research, Oxford University Press.

 C The Author(s) 2016. Published by Oxford University Press on behalf of Nucleic Acids Research. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

Editorial: CRISPR in Nucleic Acids Research.

Editorial: CRISPR in Nucleic Acids Research. - PDF Download Free
38KB Sizes 0 Downloads 11 Views